相关实验视频

Updated: Jun 29, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Circ_0049271针对miR-1197/PTRF轴,以减轻骨髓瘤的恶性病变

Yixin Wen^1,1, Feng Xu^1,1, Hui Zhang¹

¹Orthopaedics Department, Fifth Hospital of Wuhan, Wuhan, Hubei, China.

Cancer biomarkers : section A of Disease markers

|April 5, 2024

概括

循环RNAcirc_0049271通过准microRNA-1197来调节聚合酶1和转录释放因子 (PTRF) 来抑制骨肉瘤的进展. 这表明circ_0049271是骨髓瘤的潜在治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

循环RNAs (circRNAs) 在骨髓瘤 (OS) 的发展中起着至关重要的作用.
了解OS中circRNAs的特定机制对于开发新疗法至关重要.

研究的目的:

研究circ_0049271在骨髓瘤进展中的功能作用和潜在机制.
探索OS中circ_0049271,microRNA-1197 (miR-1197) 和聚合酶1和转录释放因子 (PTRF) 之间的调节关系.

主要方法:

细胞测试 (殖民地形成,CCK-8,Transwell) 用于评估OS细胞的增殖和入侵.
定量逆转录-聚合酶连锁反应和西部抹杀评估了关键分子的表达水平.
RNA免疫沉和双光酶测定确定了分子相互作用.
在体内瘤形成试验中,评估了circ_0049271对瘤生长的影响.

主要成果:

骨髓瘤细胞表现出高的miR-1197表达和低的circ_0049271和PTRF水平.
circ_0049271直接针对miR-1197,从而调节PTRF的表达.
过度表达circ_0049271或PTRF抑制了OS细胞的增殖和入侵,而miR-1197的上调促进了这些过程.
在体内,circ_0049271抑制了瘤生长,而PTRF过度表达抵消了miR-1197.7的致癌作用.

结论:

circ_0049271通过向miR-1197/PTRF轴,在骨髓瘤中起到瘤抑制作用.
这种circRNA介导的途径为骨髓瘤治疗提供了潜在的治疗策略.

关键词:

骨质肉瘤骨质肉瘤是什么对于PTRF来说,这是一个很好的选择.环RNA 环RNA 是一个环RNA.环_0049271 在线观看在线观看在 miR-1197 里.

更多相关视频

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...